Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases

2013 ◽  
Vol 84 (4) ◽  
pp. 240-244 ◽  
Author(s):  
Christine J. O'Neill ◽  
Nicholas Coorough ◽  
James C. Lee ◽  
Joshua Clements ◽  
Leigh W. Delbridge ◽  
...  
2010 ◽  
Vol 199 (4) ◽  
pp. 485-490 ◽  
Author(s):  
Michal Mekel ◽  
Antonia E. Stephen ◽  
Randall D. Gaz ◽  
Gregory W. Randolph ◽  
Sara Richer ◽  
...  

Medicine ◽  
2019 ◽  
Vol 98 (30) ◽  
pp. e16659 ◽  
Author(s):  
Karl Schwaiger ◽  
Fabian Koeninger ◽  
Julia Wimbauer ◽  
Klemens Heinrich ◽  
Alexandra Gala-Kokalj ◽  
...  

2014 ◽  
Vol 21 (6) ◽  
pp. 1884-1890 ◽  
Author(s):  
Su-jin Kim ◽  
Seog Yun Park ◽  
You Jin Lee ◽  
Eun Kyung Lee ◽  
Seok-ki Kim ◽  
...  

2012 ◽  
Vol 97 (8) ◽  
pp. 2706-2713 ◽  
Author(s):  
E. Robenshtok ◽  
S. Fish ◽  
A. Bach ◽  
Jose M. Domínguez ◽  
A. Shaha ◽  
...  

Abstract Context: The risk of loco-regional recurrence in papillary thyroid cancer (PTC) patients ranges from 15–30%. However, the clinical significance of small-volume loco-regional recurrence detected by highly sensitive ultrasonography is unclear. Objective: Our objective was to describe the natural history of abnormal cervical lymph nodes (LN) diagnosed after initial treatment. Design: We conducted a retrospective cohort study. Patients: 166 PTC with patients who had at least one abnormal LN outside the thyroid be on ultrasound and selected for active surveillance were included. Main Outcome Measure: LN growth during a period of active surveillance was the primary outcome. Results: Most patients had classical PTC (85%) and an intermediate risk of recurrence (77%). The median LN size at the start of the observation period was 1.3 cm (range, 0.5–2.7 cm) in largest diameter, with all nodes having at least one abnormal sonographic characteristic (70% of patients had LN with at least two abnormal features). In almost all patients, the LN were in the lateral neck, primarily in levels 3 (43%) and 4 (58%). After a median follow-up of 3.5 yr, only 20% (33 of 166) grew at least 3 mm, 9% (15 of 166) grew at least 5 mm, and 14% (23 of 166) resolved. None of the clinical or sonographic features were predictive of LN growth (positive predictive value range = 0.21–0.57). There were no local complications (nerve damage or local invasion) related to the abnormal nodes and no disease-related mortality. Conclusions: Suspicious cervical LN in the lateral neck usually remain stable for long periods of time in properly selected PTC patients and can be safely followed with serial ultrasounds


2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Cortney Y. Lee ◽  
Samuel K. Snyder ◽  
Terry C. Lairmore ◽  
Sean C. Dupont ◽  
Daniel C. Jupiter

Ultrasound is the recommended staging modality for papillary thyroid cancer. Surgeons proficient in US assessment of the neck and experienced in the management of papillary thyroid cancer (PTC) appear uniquely qualified to assess the lateral cervical lymph nodes for metastatic disease. Of 310 patients treated for PTC between 2000 and 2008, 109 underwent surgeon-performed ultrasound (SUS) of the lateral neck preoperatively. Fine needle aspiration was performed on suspicious lateral lymph nodes. SUS findings were compared with FNA cytology and results of postoperative imaging studies. The sensitivity and negative predictive value of SUS were 88% and 97%, respectively. Four patients were found to have missed metastatic disease within 6 months. No patient underwent a nontherapeutic neck dissection. SUS combined with US-guided FNA of suspicious lymph nodes can accurately stage PTC to reliably direct surgical management.


Sign in / Sign up

Export Citation Format

Share Document